论文部分内容阅读
目的了解住院肿瘤患者医院感染现患率情况及危险因素,为制定干预措施提供依据。方法采用横断面调查的方法,对本医院住院肿瘤患者医院感染现患率及危险因素进行调查。结果在调查的时间点该医院住院肿瘤患者共237例,发生27例合并感染(含医院获得性感染和社区获得性感染),总感染率为11.39%;其中医院获得性感染8例,医院感染现患率为3.38%;社区获得性感染19例,社区感染率为8.02%。肿瘤病人并发感染以呼吸道感染为主,占总感染人数的77.78%。放化疗的肿瘤病人预防性使用抗菌药物约占40%,手术治疗的肿瘤病人预防性用药比例达到70%以上。结论肿瘤病人合并感染的比例较高,但医院内获得感染远低于社区获得感染,应积极开展社区干预,提高肿瘤放化疗患者的生存质量。
Objective To understand the prevalence rate and risk factors of nosocomial infections in hospitalized patients with cancer and provide basis for making interventions. Methods The method of cross-sectional survey was used to investigate the prevalence and risk factors of nosocomial infections in hospitalized patients with cancer. Results A total of 237 hospitalized patients with cancer were hospitalized at the time of the survey. Twenty-seven patients had a combined infection (hospital-acquired infection and community-acquired infection) with a total infection rate of 11.39%. Eight hospital-acquired infections and nosocomial infections The prevalence rate was 3.38%; community acquired infection in 19 cases, the community infection rate was 8.02%. Tumor patients complicated by infection mainly respiratory infections, the total number of infected 77.78%. Chemotherapy for cancer patients with preventive use of antimicrobial drugs account for about 40%, surgical treatment of cancer patients prophylactic drug use rate reached more than 70%. Conclusion The proportion of patients with cancer is higher, but the infection rate in hospital is much lower than that of community. Therefore, community intervention should be actively carried out to improve the quality of life of patients receiving radiotherapy and chemotherapy.